Chemed Corporation $CHE Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC reduced its stake in Chemed Corporation (NYSE:CHE) by 18.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,714 shares of the company’s stock after selling 6,523 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.20% of Chemed worth $12,856,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Smartleaf Asset Management LLC increased its holdings in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares during the period. First Horizon Corp acquired a new position in shares of Chemed during the third quarter worth about $31,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Chemed during the third quarter worth approximately $45,000. Parkside Financial Bank & Trust increased its stake in shares of Chemed by 86.3% during the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after buying an additional 44 shares during the period. Finally, HM Payson & Co. raised its holdings in Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after acquiring an additional 27 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Up 0.7%

Shares of Chemed stock opened at $424.52 on Wednesday. Chemed Corporation has a 52-week low of $385.00 and a 52-week high of $623.60. The company’s 50-day simple moving average is $445.63 and its 200-day simple moving average is $443.55. The firm has a market cap of $5.85 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 1.57 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The firm had revenue of $639.34 million during the quarter, compared to analyst estimates of $659.09 million. During the same quarter in the previous year, the business earned $6.83 EPS. Chemed’s revenue for the quarter was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Equities research analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be issued a $0.60 dividend. The ex-dividend date of this dividend is Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 13.06%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CHE shares. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer lowered their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 target price (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $498.00.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.